Sopharma AD operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sopharma AD with three other
drug stores in Europe:
Dermapharm Holding SE
sales of 467.12 million Euro [US$545.06 million]
of which 52%
was Parallel import Business),
(527.66 million Euro [US$615.70 million]
Aptechnaya set' 36,6' PAO
based in Russia
(48.25 billion Russian Rubles [US$716.56 million]
of which 100%
Sopharma AD reported sales of 1.03 billion Bulgarian Lev (US$611.91 million)
December of 2017.
increase of 15.8%
versus 2016, when the company's sales were 885.38 million Bulgarian Lev.
Sales of Distribution of Pharmaceutical Products saw an increase
20.7% in 2017, from
628.08 million Bulgarian Lev to 757.98 million Bulgarian Lev.
Not all segments of Sopharma AD experienced an increase in sales in 2017:
sales of Other Business Segment fell 36.9% to 16.29 million Bulgarian Lev.
(However, this segment's sales were only a very small portion of the company's overall sales).